Lexicon Pharmaceuticals (LXRX) Inventory (2017 - 2026)

Lexicon Pharmaceuticals' (LXRX) quarterly Inventory came in at $276000.0 in Q1 2026, up 37.31% year-on-year from $201000.0 in Q1 2025, and down 1.78% on a QoQ basis from $281000.0 in Q4 2025.

Lexicon Pharmaceuticals (LXRX) Inventory (2017 - 2026) Analysis & Trends

Lexicon Pharmaceuticals (LXRX) has 8 years of Inventory data on file, last reported at $276000.0 in Q1 2026.

  • On a quarterly basis, Inventory rose 37.31% year-over-year to $276000.0 in Q1 2026; TTM through Mar 2026 was $276000.0, a 37.31% increase from a year earlier, with the FY2025 full-year figure at $281000.0, up 21.65% from the prior year.
  • Inventory for Q1 2026 stood at $276000.0, down from $281000.0 in the prior quarter.
  • Over the last five years, Inventory for LXRX reached as high as $636000.0 in Q3 2024 and fell as low as $158000.0 in Q3 2025.
  • Historically, Inventory has averaged $328250.0 across 4 years, with a median of $278500.0 in 2025.
  • Across the five-year window, Inventory jumped 240.12% in 2024 and slumped 75.16% in 2025, its largest moves.
  • Year by year, Inventory stood at $381000.0 in 2023, then tumbled by 39.37% to $231000.0 in 2024, then rose by 21.65% to $281000.0 in 2025, then fell by 1.78% to $276000.0 in 2026.
  • Per Business Quant data, the three most recent Inventory figures were $276000.0 in Q1 2026, $281000.0 in Q4 2025, and $158000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 681.59 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.77 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 3.10 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 371.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Lexicon Pharmaceuticals 979.13 Mn 808.47 Mn 20.99 Mn 276,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 276,000.00
Dec 31, 2025 281,000.00
Sep 30, 2025 158,000.00
Jun 30, 2025 168,000.00
Mar 31, 2025 201,000.00
Dec 31, 2024 231,000.00
Sep 30, 2024 636,000.00
Jun 30, 2024 585,000.00
Mar 31, 2024 514,000.00
Dec 31, 2023 381,000.00
Sep 30, 2023 336,000.00
Jun 30, 2023 172,000.00
Jun 30, 2020 3.99 Mn
Mar 31, 2020 4.15 Mn
Dec 31, 2019 4.24 Mn
Sep 30, 2019 4.48 Mn
Jun 30, 2019 4.28 Mn
Mar 31, 2019 4.61 Mn
Dec 31, 2018 4.68 Mn
Sep 30, 2018 4.76 Mn